Tozaro
Develops synthetic affinity polymers using computational molecular modelling, monomer library screening and molecular imprinting for applications in viral vector analytics, capture chromatography and diagnostic reagents. Activities described include prototype development, scale-up chemical manufacturing, publication of technical posters, and management of an intellectual property portfolio.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Synthetic affinity polymers for viral vector analytics
Synthetic affinity polymers designed to bind viral epitopes for use in quantification and enrichment workflows.
Synthetic affinity polymers for viral vector purification
Affinity ligands engineered for capture chromatography to selectively bind and release viral vectors under mild conditions.
Synthetic detection reagents for rapid diagnostics
Non-biological detection reagents intended for rapid diagnostic formats and high-throughput IVD platforms.
Synthetic affinity polymers for viral vector analytics
Synthetic affinity polymers designed to bind viral epitopes for use in quantification and enrichment workflows.
Synthetic affinity polymers for viral vector purification
Affinity ligands engineered for capture chromatography to selectively bind and release viral vectors under mild conditions.
Synthetic detection reagents for rapid diagnostics
Non-biological detection reagents intended for rapid diagnostic formats and high-throughput IVD platforms.
Services
Design of synthetic affinity polymers tailored to specific viral epitopes and end-use applications (analytics or purification).
Development and deployment of enrichment and assay workflows using synthetic polymers with platforms such as biolayer interferometry and LC–MS.
Development of capture chromatography ligands and protocols intended to improve viral vector yields and enable milder elution conditions.
Design of synthetic affinity polymers tailored to specific viral epitopes and end-use applications (analytics or purification).
Development and deployment of enrichment and assay workflows using synthetic polymers with platforms such as biolayer interferometry and LC–MS.
Development of capture chromatography ligands and protocols intended to improve viral vector yields and enable milder elution conditions.
Expertise Areas
- Synthetic affinity ligand development
- Molecular imprinting and polymer chemistry
- Viral vector analytics and quantification
- Affinity capture chromatography for viral purification
Key Technologies
- Molecularly imprinted polymers (MIPs)
- In silico molecular modelling
- Large-scale monomer library screening
- Controlled chemical polymer synthesis
News & Updates
Company representatives scheduled to attend Bio International Convention and available for meetings (June 16–19, 2025).
Company representatives scheduled to attend the ASCGT annual meeting (May 13–17, 2025).
Appointment of Jason Slingsby as Chief Executive Officer, effective 22 April 2025.
Consortium funding to develop tools for lentiviral production in partnership with external organisations.
Technical demonstration of affinity enrichment workflows and femtomole-level detection of a viral spike protein using synthetic affinity polymers.
From in silico modelling to application: development and evaluation of affinity polymers for lentivirus quantification.
Company representatives scheduled to attend Bio International Convention and available for meetings (June 16–19, 2025).
Company representatives scheduled to attend the ASCGT annual meeting (May 13–17, 2025).
Appointment of Jason Slingsby as Chief Executive Officer, effective 22 April 2025.
Consortium funding to develop tools for lentiviral production in partnership with external organisations.
Technical demonstration of affinity enrichment workflows and femtomole-level detection of a viral spike protein using synthetic affinity polymers.
From in silico modelling to application: development and evaluation of affinity polymers for lentivirus quantification.